Evidence map›Paper›PMID 36504277›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2023

[

Atia Samim, Thomas Blom, Alex J Poot, Albert D Windhorst, Marta Fiocco, Nelleke Tolboom, Arthur J A T Braat, Sebastiaan L Meyer Viol, Rob van Rooij, Max M van Noesel and 3 more

Erratum issuedOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  3. Trial
  4. [European journal of nuclear medicine and molecular imaging · 2023
    Trial
  5. Review
  6. Uptake Patterns of Peripheral Ganglia onEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Head-to-head comparison of [Pediatric radiology · 2026
    Review
  8. Article
  9. hNET-targeted [Theranostics · 2026
    Article
  10. [European journal of nuclear medicine and molecular imaging · 2026
    Observational
  11. Comprehensive analysis of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  12. Review
  13. Lesion Analysis ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  14. SUV normalisation and reference tissue selection for [European journal of nuclear medicine and molecular imaging · 2025
    Observational
  15. Review
  16. Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  17. Leveraging small voxel with optimal acquisition time for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  18. Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  19. [Frontiers in oncology · 2025
    Article
  20. Performing [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Atia SamimPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Thomas BlomPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Alex J PootPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Albert D WindhorstDepartment of Radiology and Nuclear Medicine, Cancer Centre Amsterdam, Amsterdam University Medical Centres, Amsterdam, Netherlands.
Marta FioccoPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Nelleke TolboomPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Arthur J A T BraatPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Sebastiaan L Meyer ViolPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Rob van RooijPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Max M van NoeselPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Marnix G E H LamPrincess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Godelieve A M Tytgat *Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands.
Bart de Keizer *Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, Netherlands. b.dekeizer@umcutrecht.nl.ORCID 0000-0002-6270-9483
University Medical Center Utrecht · NLLeiden University · NL

Funding

Stichting Kinderen Kankervrij 327
6 · The paper itself

Abstract

purposeMeta-[

methodsIn a prospective, single-centre study, we recruited children with neuroblastoma, referred for meta-[

resultsTwenty paired [

conclusionResults of this study demonstrate feasibility of [

trial registrationDutch Trial Register NL8152.

Indexed as

NeuroblastomaPositron Emission Tomography Computed Tomography3-IodobenzylguanidineChild, PreschoolHumansIodine RadioisotopesPilot ProjectsPositron-Emission TomographyProspective Studies3-IodobenzylguanidineIodine-123Iodine Radioisotopes[123I]mIBG[18F]mFBGNeuroblastomaNuclear medicine imagingPaediatric oncologyPET-CT

Identifiers

PMID36504277
PMCPMC9931849
OpenAlexW4311125423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.